Please note: The information displayed on this page might be outdated.
Immunicum AB: Immunicum is establishing a unique immuno-oncology approach through the development of allogeneic, off-the-shelf cell-based therapies. Immunicum's goal is to improve survival outcomes and quality of life by priming the patient’s own immune system to fight cancer. The company’s lead product ilixadencel, consisting of pro-inflammatory allogeneic dendritic cells, has the potential to become a backbone component of modern cancer combination treatments in a variety of solid tumor indications. 
Based in...
Clinical Stage
Phase III
Disease Space
Europe, Public
Market Cap
Therapeutic Modalities
Östermalmstorg 5
Stockholm, 114 42

Company Participants at European Biotech Investor Day 2019

  • Carlos De Sousa, MD, MBA, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Immunicum AB

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fjärde AP-fonden 7.59 7,000,000 7.57 Stakes 2019-09-30
Max Mitteregger Kapitalförvaltning AB 3.94 3,631,071 3.93 Stakes 2019-09-30
Andra AP-fonden 1.25 1,150,000 1.24 Stakes 2019-09-30
Alfred Berg Kapitalförvaltning AB 1.05 966,020 1.04 Stakes 2019-09-30
SEB Investment Management AB 0.84 772,121 0.83 Stakes 2019-09-30
Handelsbanken Fonder AB 0.83 762,723 0.82 Funds 2020-06-30
Swedbank Robur Fonder AB 0.64 587,249 0.64 Stakes 2019-09-30
Skandia Investment Management AB 0.04 40,015 0.04 Funds 2020-04-30
Storebrand Asset Management AS 0.04 33,343 0.04 Funds 2020-06-30
Catella Fondförvaltning AB 0.02 21,000 0.02 Funds 2020-05-29
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.